Brandon Folkes
Stock Analyst at Rodman & Renshaw
(0)
# 4717
Out of 5,333 analysts
71
Total ratings
24.39%
Success rate
-21.20%
Average return
Main Sectors:
| Name | Action | PT | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
RMTI Rockwell Medical | Initiates Coverage On: Buy | 5 | 1.11 | 350.45% | 1 | Nov 14, 2024 | |
ACHV Achieve Life Science... | Initiates Coverage On: Buy | 12 | 2.34 | 412.82% | 1 | Nov 14, 2024 | |
EPRX Eupraxia Pharmaceuti... | Initiates Coverage On: Buy | 9 | 3.8 | 136.84% | 1 | Nov 14, 2024 | |
OMER Omeros | Initiates Coverage On: Buy | 9 | 6.17 | 45.87% | 2 | Nov 14, 2024 | |
ADIL Adial Pharmaceutical... | Initiates Coverage On: Buy | 8 | 0.61 | 1211.48% | 1 | Nov 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 16 16 | 5.66 | 182.69% | 6 | Sep 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 13 | 11.65 | 11.59% | 1 | Aug 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 9 | 1.11 | 710.81% | 1 | Aug 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 8 | 4.55 | 75.82% | 1 | Jun 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 7 | 6.6 | 6.06% | 1 | Jun 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 7 | 2.1 | 233.33% | 1 | Jun 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 10 | 0.73 | 1269.86% | 2 | Jun 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 455 | 4.02 | 11218.41% | 1 | Jun 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Overweight | 59 | 32.37 | 82.27% | 4 | Sep 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Overweight | 8 | n/a | n/a | 4 | Sep 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Overweight | 180 | 97.82 | 84.01% | 2 | Aug 22, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 25 15 | n/a | n/a | 2 | Jan 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 30 22 | 0.51 | 4213.73% | 3 | Dec 5, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Overweight | 5 | n/a | n/a | 1 | Nov 2, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Overweight | 6 | n/a | n/a | 1 | Jun 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Overweight | 9 | 6.82 | 31.96% | 1 | Feb 25, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Overweight | 28 32 | 30.16 | 6.1% | 3 | Jan 27, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Overweight | 40 | n/a | n/a | 1 | Sep 22, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Overweight | 22000 | 1.99 | 1105427.64% | 1 | Aug 31, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 30 22 | 28.89 | -23.85% | 5 | Aug 6, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Overweight | 720 | 2.77 | 25892.78% | 1 | Jul 30, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Overweight | 3125 | n/a | n/a | 1 | Aug 28, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 38 53 | n/a | n/a | 4 | Aug 20, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 78 40 | 66.28 | -39.65% | 3 | May 7, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Overweight | 405 315 | 9.39 | 3254.63% | 3 | Mar 5, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 58 46 | n/a | n/a | 6 | Mar 2, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 32 42 | n/a | n/a | 2 | Sep 28, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 42 50 | 20.3 | 146.31% | 1 | Jul 12, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 7 4 | n/a | n/a | 2 | Mar 13, 2018 |